Institutional Ownership Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS). We have compiled data on the 177 institutions that hold shares in the stock, with a total of 30.1 Million shares, which have been reported (via 13F filing form) to have a value of $362 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Russell Investments Group, Ltd.
|
Nov 13, 2024 Q3 2024 |
102,316
shares
|
$1.21 Million
0.01% of portfolio
|
Q3 2024
Added 24.24%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
101,050
shares
|
$1.2 Million
0.34% of portfolio
|
Q3 2024
Added 202.95%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
92,110
shares
|
$1.09 Million
0.0% of portfolio
|
Q3 2024
Added 543.81%
|
|
|
Stem Point Capital LP
New York, NY |
Nov 13, 2024 Q3 2024 |
86,930
shares
|
$1.03 Million
1.51% of portfolio
|
Q3 2024
New holding
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Nov 14, 2024 Q3 2024 |
73,754
shares
|
$873,247
1.1% of portfolio
|
Q3 2024
Added 8.86%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 14, 2024 Q3 2024 |
71,740
shares
|
$849,401
0.01% of portfolio
|
Q1 2024
New holding
|
|
|
Altium Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
69,000
shares
|
$816,960
1.41% of portfolio
|
Q3 2024
New holding
|
|
|
Assenagon Asset Management S.A.
|
Jan 14, 2025 Q4 2024 |
64,937
shares
|
$768,854
0.0% of portfolio
|
Q4 2024
Reduced 70.97%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
60,178
shares
|
$712,507
0.0% of portfolio
|
Q3 2024
Added 34.04%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
60,014
shares
|
$710,565
0.0% of portfolio
|
Q3 2024
Added 140.13%
|
|
|
Fred Alger Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
59,138
shares
|
$700,193
0.02% of portfolio
|
Q3 2024
Added 20.71%
|
|
|
Swiss National Bank
Zurich, V8 |
Nov 07, 2024 Q3 2024 |
56,300
shares
|
$666,592
0.0% of portfolio
|
Q3 2024
Reduced 0.88%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
55,907
shares
|
$661,938
0.0% of portfolio
|
Q3 2024
Reduced 14.72%
|
|
|
J. Goldman & CO LP
New York, NY |
Nov 14, 2024 Q3 2024 |
54,236
shares
|
$642,154
0.1% of portfolio
|
Q3 2024
Added 80.17%
|
|
|
High Vista Strategies LLC
Boston, MA |
Nov 14, 2024 Q3 2024 |
52,107
shares
|
$616,946
1.18% of portfolio
|
Q3 2024
Added 32.9%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
50,552
shares
|
$598,535
0.0% of portfolio
|
Q3 2024
Added 4.7%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
43,500
shares
|
$515,040
0.0% of portfolio
|
Q3 2024
Added 94.4%
|
|
|
Rafferty Asset Management, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
41,112
shares
|
$486,766
0.01% of portfolio
|
Q3 2024
Reduced 28.57%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
40,476
shares
|
$479,235
0.0% of portfolio
|
Q3 2024
Reduced 2.79%
|
|
|
Engineers Gate Manager LP
New York, NY |
Nov 14, 2024 Q3 2024 |
39,669
shares
|
$469,680
0.05% of portfolio
|
Q3 2024
Reduced 17.02%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
34,162
shares
|
$404,478
0.0% of portfolio
|
Q1 2024
Added 28.23%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
31,827
shares
|
$376,831
0.0% of portfolio
|
Q2 2024
Added 25.03%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Dec 26, 2024 Q3 2024 |
31,117
shares
|
$368,425
0.0% of portfolio
|
Q3 2024
Added 1.37%
|
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
29,319
shares
|
$347,136
0.01% of portfolio
|
Q3 2022
Added 134.55%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
27,941
shares
|
$330,821
0.0% of portfolio
|
Q3 2024
Reduced 10.55%
|